These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 17954711)

  • 1. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
    Tuttle TM; Habermann EB; Grund EH; Morris TJ; Virnig BA
    J Clin Oncol; 2007 Nov; 25(33):5203-9. PubMed ID: 17954711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
    Tuttle TM; Jarosek S; Habermann EB; Arrington A; Abraham A; Morris TJ; Virnig BA
    J Clin Oncol; 2009 Mar; 27(9):1362-7. PubMed ID: 19224844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
    Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
    Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are mastectomy rates really increasing in the United States?
    Habermann EB; Abbott A; Parsons HM; Virnig BA; Al-Refaie WB; Tuttle TM
    J Clin Oncol; 2010 Jul; 28(21):3437-41. PubMed ID: 20548000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contralateral prophylactic mastectomy for patients with unilateral breast cancer.
    Tuttle T; Habermann E; Abraham A; Emory T; Virnig B
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1117-22. PubMed ID: 18028020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
    J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should the use of contralateral prophylactic mastectomy be increasing as it is?
    Wood WC
    Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005.
    McLaughlin CC; Lillquist PP; Edge SB
    Cancer; 2009 Dec; 115(23):5404-12. PubMed ID: 19787635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution.
    Jones NB; Wilson J; Kotur L; Stephens J; Farrar WB; Agnese DM
    Ann Surg Oncol; 2009 Oct; 16(10):2691-6. PubMed ID: 19506956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy.
    Geiger AM; West CN; Nekhlyudov L; Herrinton LJ; Liu IL; Altschuler A; Rolnick SJ; Harris EL; Greene SM; Elmore JG; Emmons KM; Fletcher SW
    J Clin Oncol; 2006 Mar; 24(9):1350-6. PubMed ID: 16549829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
    Isern AE; Tengrup I; Loman N; Olsson H; Ringberg A
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1177-87. PubMed ID: 17938010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the impact of breast reconstruction on the surgical decision-making process for breast cancer.
    Alderman AK; Hawley ST; Waljee J; Mujahid M; Morrow M; Katz SJ
    Cancer; 2008 Feb; 112(3):489-94. PubMed ID: 18157830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
    Goldflam K; Hunt KK; Gershenwald JE; Singletary SE; Mirza N; Kuerer HM; Babiera GV; Ames FC; Ross MI; Feig BW; Sahin AA; Arun B; Meric-Bernstam F
    Cancer; 2004 Nov; 101(9):1977-86. PubMed ID: 15389473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's decision-making roles regarding contralateral prophylactic mastectomy.
    Nekhlyudov L; Bower M; Herrinton LJ; Altschuler A; Greene SM; Rolnick S; Elmore JG; Harris EL; Liu A; Emmons KM; Fletcher SW; Geiger AM
    J Natl Cancer Inst Monogr; 2005; (35):55-60. PubMed ID: 16287886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of age on the breast surgery decision-making process.
    Bleicher RJ; Abrahamse P; Hawley ST; Katz SJ; Morrow M
    Ann Surg Oncol; 2008 Mar; 15(3):854-62. PubMed ID: 18058182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy.
    Sorbero ME; Dick AW; Beckjord EB; Ahrendt G
    Ann Surg Oncol; 2009 Jun; 16(6):1597-605. PubMed ID: 19330381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and outcomes of contralateral breast cancers.
    Quan G; Pommier SJ; Pommier RF
    Am J Surg; 2008 May; 195(5):645-50; discussion 650. PubMed ID: 18424281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mastectomy and contralateral prophylactic mastectomy rates: an institutional review.
    Damle S; Teal CB; Lenert JJ; Marshall EC; Pan Q; McSwain AP
    Ann Surg Oncol; 2011 May; 18(5):1356-63. PubMed ID: 21125335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database.
    Garcia-Etienne CA; Tomatis M; Heil J; Friedrichs K; Kreienberg R; Denk A; Kiechle M; Lorenz-Salehi F; Kimmig R; Emons G; Danaei M; Heyl V; Heindrichs U; Rageth CJ; Janni W; Marotti L; del Turco MR; Ponti A;
    Eur J Cancer; 2012 Sep; 48(13):1947-56. PubMed ID: 22483323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing rates of contralateral prophylactic mastectomy - a trend made in USA?
    Güth U; Myrick ME; Viehl CT; Weber WP; Lardi AM; Schmid SM
    Eur J Surg Oncol; 2012 Apr; 38(4):296-301. PubMed ID: 22305274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.